Cargando…
Timing of VV‐ECMO therapy implementation influences prognosis of COVID‐19 patients
INTRODUCTION: Current knowledge on the use of extracorporeal membrane oxygenation (ECMO) in COVID‐19 remains limited to small series and registry data. In the present retrospective monocentric study, we report on our experience, our basic principles, and our results in establishing and managing ECMO...
Autores principales: | Giraud, Raphaël, Legouis, David, Assouline, Benjamin, De Charriere, Amandine, Decosterd, Dumeng, Brunner, Marie‐Eve, Moret‐Bochatay, Mallory, Fumeaux, Thierry, Bendjelid, Karim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7851435/ https://www.ncbi.nlm.nih.gov/pubmed/33527751 http://dx.doi.org/10.14814/phy2.14715 |
Ejemplares similares
-
Can VA-ECMO Be Used as an Adequate Treatment in Massive Pulmonary Embolism?
por: Giraud, Raphaël, et al.
Publicado: (2021) -
A Dedicated Expert ECMO-Team and Strict Patient Selection Improve Survival of Patients with Severe SARS-CoV-2 ARDS Supported by VV-ECMO
por: Giraud, Raphaël, et al.
Publicado: (2022) -
ECMO in Cardiac Arrest: A Narrative Review of the Literature
por: De Charrière, Amandine, et al.
Publicado: (2021) -
The use of extracorporeal CO(2) removal in acute respiratory failure
por: Giraud, Raphaël, et al.
Publicado: (2021) -
Prolonged VV ECMO: Navigating the Unchartered Sea
por: Kumar, Vivek
Publicado: (2023)